M. Seybold
Allergan (Germany)(DE)
Publications by Year
Research Areas
Allergic Rhinitis and Sensitization, Dermatology and Skin Diseases, Food Allergy and Anaphylaxis Research, Asthma and respiratory diseases, Plant Reproductive Biology
Most-Cited Works
- → Electrogastrography as a diagnostic tool for delayed gastric emptying in functional dyspepsia and irritable bowel syndrome(2003)51 cited
- → Short‐course subcutaneous treatment with PQ Grass strongly improves symptom and medication scores in grass allergy(2023)23 cited
- → A Tyrosine Adsorbed Modified Grass Allergen + MPL SCIT Demonstrates Clinically Improvement in Combined Symptom and Medication Score in Subjects with Seasonal Allergic Rhinitis and/or Rhinoconjunctivitis(2022)1 cited
- → Supportive Short-term Safety Profile In Pediatric Participants For PQ Grass In a Phase III Long-term Adaptive Pediatric Trial(2026)
- → Positives Ergebnis der zulassungsrelevanten Phase-III-Studie mit PQ Grass 27600 SU, einem modifizierten Gräserallergen-Produkt für die subkutane Immuntherapie (SCIT) unter Verwendung von mikrokristallinem Tyrosin (MCT) und Monophosphoryllipid A (MPL) als Adjuvans-System(2025)
- → PQ Grass 27600 SU effectively induces tolerogenic properties through modulation of humoral and cellular immune responses for the treatment of seasonal allergic rhinitis(2026)
- → Title of Article: Response to Correspondence ALL-2023-01107 “Short-course subcutaneous treatment with PQ Grass strongly improves symptom and medication scores in grass allergy”(2024)
- → Positive outcome of the pivotal Phase III study with PQ Grass 27600 SU, a modified grass allergen subcutaneous immunotherapy (SCIT) product using MicroCrystalline Tyrosine (MCT) and Monophosphoryl Lipid A (MPL) as adjuvant system(2025)
- → Safety profile of the first year of a paediatric long-term study investigating the safety and efficacy of subcutaneous immunotherapy with PQ Grass 27 600 SU: An Innovative Trial Design(2026)
- → Response to Correspondence ALL-2023-01107 “Short-course subcutaneous treatment with PQ Grass strongly improves symptom and medication scores in grass allergy”(2024)